Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
SSE:688068
Price:
28.19 CNY
1.48%
Market Closed
Updated:
Jun 9, 2024
Beijing Hotgen Biotech Co Ltd
Total Liabilities & Equity
|
Beijing Hotgen Biotech Co Ltd
Total Liabilities & Equity Peer Comparison
Comparables:
603259
300759
2269
300347
M
688114
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Total Liabilities & Equity
¥3.6B
|
CAGR 3-Years
58%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Total Liabilities & Equity
¥73.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Total Liabilities & Equity
¥26.5B
|
CAGR 3-Years
28%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Total Liabilities & Equity
¥56.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Total Liabilities & Equity
¥29.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
46%
|
CAGR 10-Years
42%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Total Liabilities & Equity
¥11.2B
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
3.6B
CNY
3.6B
CNY
Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Total Liabilities & Equity amounts to 3.6B CNY.
What is Beijing Hotgen Biotech Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
68%
68%
Over the last year, the Total Liabilities & Equity growth was -9%. The average annual Total Liabilities & Equity growth rates for Beijing Hotgen Biotech Co Ltd have been 58% over the past three years , 68% over the past five years .
You don't have any saved screeners yet
